03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Cephadar Forte* : | |
Type | Medicine Non Marketed |
Originator | Keflex Pulvules |
Agent | Sadco |
Distributor | Sadco |
Laboratory | Dar Al Dawa |
Responsible Party | Dar Al Dawa |
Origin | Jordan |
Manufacturer | Dar Al Dawa Development & Investment |
Manufacturing Type | G |
Origin | Jordan |
ATC | J01DB01 |
Cephadar Forte* :
Cephadar Forte* :
Cephadar Forte* :
Cephadar Forte* :
Cephadar Forte* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Not known |
Agitation | Not known |
ALT increased | Not known |
Anal pruritus | Not known |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Not known |
Arthritis | Not known |
AST increased | Not known |
Confusion | Not known |
Diarrhoea (Diarrhea) | Common |
Dizziness | Not known |
Dyspepsia | Not known |
Eosinophilia | Not known |
Erythema multiforme | Rare |
Fatigue | Not known |
Genital candidiasis | Not known |
Haemolytic anemia | Not known |
Hallucination | Not known |
Headache | Not known |
Hepatitis | Rare |
Interstitial nephritis | Rare |
Jaundice cholestatic (Cholestatic icterus) | Rare |
Joint disorders | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Nausea | Rare |
Neutropenia | Not known |
Pruritus genital | Not known |
Pseudomembranous colitis | Not known |
Skin rash | Uncommon |
Stevens-Johnson syndrome | Rare |
Thrombocytopenia (Thrombopenia) | Not known |
Urticaria | Uncommon |
Vaginal discharge | Not known |
Vaginitis | Not known |
Vomiting | Rare |
Cephadar Forte* :
NB : Products With Same Indication |
Different Units By MoH Code
Cephadar Forte* MoH 1817 :
Form | Capsule, hard |
Packaging | Blisters |
Package Size | Box of 20 |
Strength | 500mg |
Storage Condition | <25°C None |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 28590 |
Submission date | 01/01/1995 |
Registration Year | 1995 |
Archived Date | 02/07/2020 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 20 | |
● Public Price: | 30 QAR | ( 736,740.00 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 1,5 QAR | ( 24,558.00 LBP ) |
● Pharmacy Price: | 24.06266785 QAR | ( 590930.9970603 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 20 | |
● Public Price: | 19.5 AED | ( 471,139.50 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,975 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 15.92 AED | ( 384643.12 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 20's (10's Blister x 2) | |
● Public Price: | 19.5 AED | ( 471,139.50 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,975 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 15.92 AED | ( 384643.12 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 100ml | |
● Public Price: | 18.1 SAR | ( 427,884.00 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,905 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 20 | |
● Public Price: | 1.88 OMR | ( 433,779.92 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,094 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 20 | |
● Public Price: | 4.12 JOD | ( 515,910.52 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,206 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 3.14 JOD | ( 393193.94 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 20 | |
● Public Price: | 4.48 BHD | ( 1,065,048.32 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,224 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File